-
Targeted sequencing DDR genes in cancer stem cells
Study
EGAS00001004892
-
Colorectal adenomas, NKI-AvL TGO series Stool-Proteomics
Study
EGAS00001002953
-
Contribution of allelic imbalance to colorectal cancer
Study
EGAS00001002966
-
Identification of Therapeutic Targets in Rhabdomyosarcoma Through Integrated Genomic, Epigenomic, and Proteomic Analyses
Study
EGAS00001002967
-
The Molecular Landscape of Asian Breast Cancers Reveals Clinically Relevant Population-Specific Differences
Study
EGAS00001004518
-
Partner-independent fusion gene detection by multiplexed CRISPR/Cas9 enrichment and long-read Nanopore sequencing
Study
EGAS00001003964
-
Spiradenocarcinoma
Study
EGAS00001001799
-
Single cell exome sequencing of lung adenocarcinoma
Study
EGAS00001002972
-
Understanding_the_multicellular_dynamics_of_clear_cell_renal_cell_carcinoma___visium
Study
EGAS00001006045
-
Targeted sequencing about core genes involved in telomere biology in colorectal cancer patients
Study
EGAS00001002977
-
Identification of the mutational consequences of precancerous liver disease (including alcohol abuse) on the genomes of human adult stem cells.
Study
EGAS00001002983
-
Tumor-specific expression of let-7i and miR-192 is associated with resistance to cisplatin-based chemoradiotherapy in patients with larynx and hypopharynx cancer
Study
EGAS00001004001
-
Role_of_HPV_and_Interferon_in_APOBEC_mutational_signature
Study
EGAS00001002988
-
A benchmarking resource for NGS testing of cancer predisposition genes
Study
EGAS00001002993
-
Host whole genome variations are associated with neurocognitive outcome in survivors of pediatric medulloblastoma
Study
EGAS00001002996
-
WGS of gastric cancer in the Japanese population (81 gastric cancers of NCC)
Study
EGAS00001006051
-
Epigenetic profiling of colorectal cancer initiating cells (CC-ICs) to identify bivalently marked genes (H3K4me3 and H3K27me3 ChIP-seq), and investigation of changes in transcriptome following EZH2 inhibition using RNA-seq.
Study
EGAS00001003003
-
Whole genome, exome and transcriptome analysis to guide individualized cancer interpretation
Study
EGAS00001004013
-
Mapping the breast cancer metastatic cascade onto circulating tumour DNA using genetic and epigenetic clonal tracking
Study
EGAS00001004014
-
Reconstruction of complex rearrangement patterns causing the initiation of clear cell renal cell carcinoma.
Study
EGAS00001004015
-
Whole Genome sequencing of colorectal cancer patients (SG-BULK-3)
Study
EGAS00001006056
-
CTCF/cohesin-binding sites are frequently mutated in cancer
Study
EGAS00001003010
-
Effect_of_FAM50_knockout_on_the_transcriptome
Study
EGAS00001004836
-
Exploring_the_landscape_of_somatic_mutations_in_normal_tissue___BD___WGS
Study
EGAS00001003014
-
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
Study
EGAS00001004888
-
The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma
Study
EGAS00001005478
-
Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer
Study
EGAS00001004030
-
RNA-seq data from Non Small Cell Lung Cancer (NSCLC) samples
Study
EGAS00001004032
-
Tumor HTG EdgeSeq from metastatic castrate resistant prostate cancer
Study
EGAS00001004852
-
Panbody_nanoseq
Study
EGAS00001005521
-
Somatic_mutation_and_clonal_evolution_in_the_human_testes___WES
Study
EGAS00001003023
-
Oesophageal_Adenocarcinoma_Organoids_Iso_Seq
Study
EGAS00001004051
-
Heterogeneous metabolic signatures are linked to cancer cell differentiation in colorectal cancer
Study
EGAS00001004064
-
Mutational Signature and Transcriptomic Classification Analyses as the Decisive Diagnostic Tools for a Cancer of Unknown Primary with Neuroendocrine Differentiation
Study
EGAS00001003026
-
Whole_Genome_Sequencing_of_Human_Organoid_Lines
Study
EGAS00001003538
-
Genomic and transcriptomic landscape of aggressive thyroid cancer
Study
EGAS00001003540
-
Whole exome sequencing data of germline and two independent primary leukemias of five patients
Study
EGAS00001001889
-
Expression-Based Subtypes Define Pathologic Response to Neoadjuvant Immune-Checkpoint Inhibitors in Muscle-Invasive Bladder Cancer
Study
EGAS00001005549
-
Spatio-temporal analysis of prostate tumors in situ suggests pre-existence of treatment-resistant clones
Study
EGAS00001006113
-
WGS_of_healhy_mesothelial_cells_and_primary_mesothelima_cell_lines
Study
EGAS00001005559
-
Mutations in the RAS/MAPK pathway drive replication repair deficient hypermutated tumors and confer sensitivity to MEK inhibition
Study
EGAS00001005008
-
Histone chaperone CHAF1A promotes proliferation and tumorigenicity in gastric cancer and impacts prognosis via context-depedent regulation of gene expression
Study
EGAS00001003064
-
Comprehensive pharmacogenomic characterization of gastric cancer
Study
EGAS00001004106
-
Ovarian cancer organoid biobank
Study
EGAS00001003073
-
Exploring_the_landscape_of_somatic_mutations_in_normal_tissue___GI___TPS___WGS
Study
EGAS00001003089
-
MicroRNA profiling by next-generation sequencing for colorectal cancer screening
Study
EGAS00001005030
-
Whole genome sequencing of a breast cancer cohort with known functional homologous recombination status
Study
EGAS00001005572
-
Somatic mutations in endometriosis and normal uterine endometrium
Study
EGAS00001003095
-
Exploring_the_landscape_of_somatic_mutations_in_normal_tissue___GI___MAP___WGS
Study
EGAS00001004122
-
Germline elongator mutations in sonic hedgehog medulloblastoma
Study
EGAS00001004126